Clinical Trials@2x
  • News

    Most Read

    • Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial
    • Moderna begins dosing in Covid-19 vaccine study in Japan
    • Reify Health extends StudyTeam platform availability for clinical trials

    Most Recent

    Clinical Trials

    Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial

    22 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Global clinical trials activity increases 14.0oY in Q4 2020
    • Total number of Covid-19 clinical trials continues to rise as cases and deaths rise
    • Orphazyme’s arimoclomol expected to be used with Zavesca after likely FDA approval in Niemann-Pick disease type C

    Most Recent

    Global clinical trials activity increases 14.0oY in Q4 2020

    22 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial

MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial

Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD

23rd January 2019
Industry Viewpoints: Clinical Trials in Asia – Key Considerations

Industry Viewpoints: Clinical Trials in Asia – Key Considerations

Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...

16th January 2019
How to Enable Greater Budget Forecasting

How to Enable Greater Budget Forecasting

Ken Olovich, R.Ph., MBA, Sourcing and Financial Director of Chorus, Eli Lilly, explains a model...

10th December 2018
Poor Communication Can Cost You – REALLY Cost You

Poor Communication Can Cost You – REALLY Cost You

Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an...

9th November 2018
To Outsource or Not to Outsource? That is the Question

To Outsource or Not to Outsource? That is the Question

Lisa Henry, Manager of Clinical Research, Cordis, discusses the merits of clinical trial outsourcing models

8th November 2018
Execution: A Key Success Factor in All Sponsor-CRO Collaborations

Execution: A Key Success Factor in All Sponsor-CRO Collaborations

Ken Getz, Tufts CSDD, examines why the sponsor-CRO dynamic often falls short of expectations

7th November 2018
The Stem Cell Emperor’s New Clothes

The Stem Cell Emperor’s New Clothes

James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global...

6th November 2018
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena

Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena

Throughout this week, CTA will spotlight the ever-changing outsourcing landscape

5th November 2018
Patient Recruitment and Retention Considerations for Clinical Trials in Latin America

Patient Recruitment and Retention Considerations for Clinical Trials in Latin America

Wagner Souza, Clinical Research Manager, AstraZeneca Brazil, shares his thoughts about the challenges of patient...

29th October 2018
How to Manage Specialist Site Payment Providers

How to Manage Specialist Site Payment Providers

Jeff Nelson, VP Program Management, Mateon Therapeutics, explores the rise of specialist payment providers

15th October 2018

Latest News

Clinical Trials

Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial

22 Jan 2021
Clinical Trials

Moderna begins dosing in Covid-19 vaccine study in Japan

22 Jan 2021
Clinical Research

Reify Health extends StudyTeam platform availability for clinical trials

21 Jan 2021
Clinical Trials

Forma doses first patient in Phase I prostate cancer treatment trial

21 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
Clinical Trials

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more